Coal Employees’ Forum Demands Rs.10,000 Minimum Pension, IDA and Better Healthcare for Coal Pensioners
-
ONE 7 India Unveils New Brand Identity and Logo, Marking a New Chapter in Its Journey
-
Nanda Bhagi Sandilya: Visionary Leadership and Conceptual Framework
-
Dr. Nilesh Vishnu Potdar Conferred Prestigious Blue Ribbon Award
-
VYLOY (zolbetuximab) in combination with chemotherapy is NOW AVAILABLE and approved for first-line treatment of eligible* adult patients with gastric or gastroesophageal junction adenocarcinoma in India

